CDSCO
The Central Drugs Laboratories have identified 41 Drug Samples to be ‘Not of Standard Quality’ (NSQ) and State Drugs Testing Laboratories have identified 70 Drugs Samples as Not of Standard Quality (NSQ) for the month of Nov 2024.
Further, 2 drug samples have been identified as ‘spurious drugs’, out of 2 samples, 1 drug sample has been picked by Bihar Drugs Control Authority and 1 sample by CDSCO (NZ), Ghaziabad. The CDSCO said that these drugs have been made by unauthorized and unknown manufacturers, using brand names owned by other companies.
The CDSCO said an investigation has been initiated in the case.
“Identification of drug samples as NSQ is done based on failure of the drug sample in one or the other specified quality parameters. The failure is specific to the drug products of the batch tested by the Govt. Laboratory and it does not warrant any concerns on the other drug products available in the market”, said the CDSCO.
As we all have stepped into New Year of 2025, this is the time to…
AIIMS has created a digital platform for a unified referral and teleconsultation network connecting all AIIMS facilities…
The Indian Medical Council of Research (ICMR) study has revealed that rampant use of antibiotic…
The former Prime Minister Dr Manmohan Singh who recently took his last breath was an…
Pancreatitis is an inflammation of the pancreas, categorized into acute and chronic forms. Acute cases…
The latest World Malaria Report 2024, released by the World Health Organization (WHO), has celebrates…